These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4198846)

  • 1. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
    Baele G; Mussche M; Vermeire P; Pannier R
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
    Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 6. Degradation products of fibrinogen and crosslinked fibrin-projected clinical applications.
    Marder VJ; Budzynski AZ
    Thromb Diath Haemorrh; 1974 Sep; 32(1):49-56. PubMed ID: 4616425
    [No Abstract]   [Full Text] [Related]  

  • 7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypofibrinolysis and thrombophilia].
    Cepelák V; Dvorák J; Cepeláková H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):456-67. PubMed ID: 6083911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hypercoagulable states with protamine sulphate tests.
    Lipinski B
    Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of determination of serum fibrin-fibrinogen degradation products in acute myocardial infarction.
    Okuno T; Nelson C
    Am J Clin Pathol; 1974 Feb; 61(2):155-9. PubMed ID: 4811734
    [No Abstract]   [Full Text] [Related]  

  • 12. [The detection of preventive hypofibronectinemia in diagnosing the development of disseminated intravascular coagulation in patients with myocardial infarction at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Soroka VR
    Ter Arkh; 1993; 65(9):22-4. PubMed ID: 8303587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
    Krug H; Gryglik J; Jasiński K; Gluszek J
    Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
    Matsuda T
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):628-36. PubMed ID: 4677378
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
    Baele G; Mussche M; Vermeire P
    Lancet; 1972 Mar; 1(7752):689-90. PubMed ID: 4125193
    [No Abstract]   [Full Text] [Related]  

  • 16. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravascular thrombus formation and problems of laboratory control in coronary insufficiency].
    Lyusow WA; Belousow JB; Parfjenow AS; Sawenkow MP; Pantschenko EP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):176-9. PubMed ID: 6177601
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of cross-linked fibrin degradation products in essential mixed cryoglobulinemia.
    Fiorini G; Toschi V; Motta A; Gagliano MG; Gibelli A
    Biomed Pharmacother; 1988; 42(9):605-7. PubMed ID: 3240365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.